ANTICOAGULANT EFFECT OF A NEW POTENT HEPARIN IN HUMAN AFTER INTRAVENOUS APPLICATION AND THE COMPARISON WITH COMMERCIALLY AVAILABLE HEPARIN

被引：0

作者：

BHARGAVA, AS ^{[1
]}

WENDT, H ^{[1
]}

GUNZEL, P ^{[1
]}

机构：

[1] SCHERING AG,RES LABS,D-1000 BERLIN 10,FED REP GER

来源：

THROMBOSIS AND HAEMOSTASIS | 1981年 / 46卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：117 / 117

页数：1

共 50 条

[31] HEPARIN REQUIRES BOTH ANTITHROMBIN AND EXTRINSIC PATHWAY INHIBITOR FOR ITS ANTICOAGULANT EFFECT IN HUMAN BLOOD
ABILDGAARD, U
LINDAHL, AK
SANDSET, PM
HAEMOSTASIS, 1991, 21 (04) : 254 - 257
[32] New class of heparin derivatives with a potent antithrombotic effect and a very limited hemorrhagic activity
Doutremepuich, C
Oualane, FA
Doutremepuich, F
Fareed, J
THROMBOSIS RESEARCH, 1996, 83 (03) : 217 - 228
[33] The anticoagulant effect of antithrombin/heparin complex. A new screening test to detect a thrombophilic tendency?
Makris, PE
van Dreden, P
BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (07) : 665 - 666
[34] THE EFFECT OF SUBOPTIMAL CONCENTRATIONS OF SODIUM CITRATE UPON THE CLOTTING TIMES OF HUMAN AND DOG BLOOD AFTER INTRAVENOUS ADMINISTRATION OF HEPARIN
LOSNER, S
VOLK, BW
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1952, 224 (06): : 673 - 678
[35] Heparin resistance and coagulation activation rebound effect after anticoagulant withdrawal: beneficiary effect of adjuvant antiplatelet therapy
Gionis, Michalis N.
Ioannou, Christos V.
Kontopodis, Nikolaos
Balalis, Konstantinos
Elalamy, Ismail
Gerotziafas, Grigoris T.
INTERNATIONAL ANGIOLOGY, 2016, 35 (02) : 170 - 177
[36] ACTIVATED PARTIAL THROMBOPLASTIN TIME AFTER HEPARIN REMOVAL (APTT/HR) IN A NEW SCHEME OF ANTICOAGULANT MONITORING
BRANSON, HE
GUPTA, N
SLATER, LM
FAGIN, A
ARMENTROUT, SA
AMERICAN JOURNAL OF HEMATOLOGY, 1982, 12 (04) : 411 - 418
[37] PLASMA ANTICOAGULANT AND NONENZYMIC FIBRINOLYTIC-ACTIVITY AFTER INTRAVENOUS-INJECTION OF HEPARIN-ANTITHROMBIN-III COMPLEX INTO ANIMALS
KUDRYASHOV, BA
PASTOROVA, VE
LYAPINA, LA
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1985, 99 (01) : 76 - 78
[38] ISOLATION AND ANTICOAGULANT PROPERTIES OF A NEW SULFATED XYLAN - COMPARISON WITH HEPARIN AND A SODIUM PENTOSAN POLYSULFATE (SP-54)
DOCTOR, VM
SAULS, V
THROMBOSIS RESEARCH, 1983, 30 (06) : 573 - 578
[39] Not all EIA-tests to detect heparin/platelet factor 4 (H/PF4)-antibodies are equal - more confusion after comparison of four commercially available assays
Bergmann, F.
Bruns, C.
Czwalinna, A.
Klemens, A.
Krell, S.
Arndt, B.
Dalluegge-Tamm, H.
Groening, A.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 542 - 542
[40] Comparison of hemorrhagic effect of heparin and human activated protein C with use of Thrombostat 4000
Katsuura, Y
Tanabe, H
Kiyoki, M
Funatsu, A
HAEMOSTASIS, 1996, 26 (04) : 203 - 209

← 1 2 3 4 5 →